Impaired cognitive functioning in patients with tyrosinemia type i receiving nitisinone

Journal of Pediatrics

Volumn 164, Issue 2, 2014, Pages 398-401

  Bendadi, Fatiha ^a   De Koning, Tom J ^a   Visser, Gepke ^a   Prinsen, Hubertus C M T ^a   De Sain, Monique G M ^a   Verhoeven Duif, Nanda ^a   Sinnema, Gerben ^a   Van Spronsen, Francjan J ^b   Van Hasselt, Peter M ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b UNIVERSITY OF GRONINGEN   (Netherlands)

Author keywords

2 2 nitro 4 trifluoromethylbenzoyl 1, 3 cyclohexanedione; NTBC

Indexed keywords

NITISINONE; PHENYLALANINE; TYROSINE;

ADOLESCENT; ADULT; AMINO ACID BLOOD LEVEL; ARTICLE; CHILD; CHILDHOOD DISEASE; CLINICAL ARTICLE; COGNITION; COGNITIVE DEFECT; COGNITIVE DEVELOPMENT; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; FEMALE; HUMAN; INTELLIGENCE; INTELLIGENCE QUOTIENT; MALE; METABOLIC REGULATION; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN RESTRICTION; SCHOOL CHILD; SIBLING; TYROSINEMIA; VERBAL BEHAVIOR; WECHSLER INTELLIGENCE SCALE; YOUNG ADULT; LIVER TRANSPLANTATION; TYROSINEMIA TYPE I;

2-[2-NITRO-4-TRIFLUOROMETHYLBENZOYL]-1, 3-CYCLOHEXANEDIONE; NTBC;

4-HYDROXYPHENYLPYRUVATE DIOXYGENASE; ADOLESCENT; CHILD; CHILD DEVELOPMENT; CHILD, PRESCHOOL; COGNITION; CROSS-SECTIONAL STUDIES; CYCLOHEXANONES; DISEASE PROGRESSION; ENZYME INHIBITORS; FEMALE; HUMANS; INCIDENCE; MALE; MILD COGNITIVE IMPAIRMENT; NETHERLANDS; NITROBENZOATES; PROGNOSIS; RISK FACTORS; TYROSINEMIAS; YOUNG ADULT;

EID: 84892829474     PISSN: 00223476     EISSN: 10976833     Source Type: Journal    
DOI: 10.1016/j.jpeds.2013.10.001     Document Type: Article

References (15)

1. G.A. Mitchell, M. Grompe, M. Lambert, and R.M. Tanguay Hypertyrosinemia C.R. Scriver, A.L. Beaudet, W.S. Sly, The metabolic and molecular bases of inherited disease 2001 McGraw-Hill New York 1777 1782
2. S. Lindstedt, E. Holme, E.A. Lock, O. Hjalmarson, and B. Strandvik Treatment of hereditary tyrosinemia type I by inhibition of 4- hydroxyphenylpyruvate dioxygenase Lancet 340 1992 813 817
3. P.A. Russo, G.A. Mitchell, and R.M. Tanguay Tyrosinemia: a review Pediatr Dev Pathol 4 2001 212 221 (Pubitemid 32423820)
4. C.R. Scott The genetic tyrosinemias Am J Med Genet C Semin Med Genet 142C 2006 121 126
5. F.J. van Spronsen, Y. Thomasse, G.P. Smit, J.V. Leonard, P.T. Clayton, and V. Fidler et al. Hereditary tyrosinemia type I: a new clinical classification with difference in prognosis on dietary treatment Hepatology 20 1994 1187 1191 (Pubitemid 24323564)
6. F.A. Wijburg, W.C.C. Reitsma, M.J.H. Slooff, F.J. van Spronsen, H.A. Koetse, and D.J. Reijngoud et al. Liver transplantation in tyrosinemia type I: the Groningen experience J Inher Metab Dis 18 1995 114 118
7. P.J. McKiernan Nitisinone in the treatment of hereditary tyrosinemia type I Drugs 66 2006 743 750 (Pubitemid 43765222)
8. E. Holme, and S. Lindstedt Nontransplant treatment of tyrosinemia Clin Liver Dis 4 2000 805 814
9. F.J. van Spronsen, C.M. Bijleveld, B.T. van Maldegem, and F.A. Wijburg Hepatocellular carcinoma in hereditary tyrosinemia type I despite 2-(2 nitro-4-3 trifluoro- methylbenzoyl)-1, 3-cyclohexanedione treatment J Pediatr Gastroenterol Nutr 40 2005 90 93 (Pubitemid 40180065)
10. C.J. Koelink, P. van Hasselt, A. van der Ploeg, M.M. van den Heuvel-Eibrink, F.A. Wijburg, and C.M. Bijleveld et al. Tyrosinemia type I treated by NTBC: how does AFP predict liver cancer? Mol Genet Metab 89 2006 310 315 (Pubitemid 44692538)
11. E. Holme, and S. Lindstedt Tyrosinemia type I and NTBC (2-(2-nitro-4-trifluoromethylbenzoyl)-1, 3-cyclohexanedione) J Inher Metab Dis 21 1998 507 517 (Pubitemid 28391503)
12. C.J. Wilson, K.G. van Wyk, J.V. Leonard, and P.T. Clayton Phenylalanine supplementation improves the phenylalanine profile in tyrosinemia J Inher Metab Dis 23 2000 677 683
13. A. Masurel-Paulet, J. Poggi-Bach, M.O. Rolland, O. Bernard, N. Guffon, and D. Dobbelaere et al. NTBC treatment in tyrosinemia type I: long-term outcome in French patients J Inher Metab Dis 31 2008 81 87
14. S.Z. Kim, K.G. Kupke, L. Ierardi-Curto, E. Holme, J. Greter, and R.M. Tanguay et al. Hepatocellular carcinoma despite long-term survival in chronic tyrosinaemia I J Inher Metab Dis 23 2000 791 804 (Pubitemid 32036713)
15. F.J. van Spronsen, G.P.A. Smit, F.A. Wijburg, Y. Thomasse, G. Visser, and H.S.A. Heymans Tyrosinemia type I: consideration of treatment strategy and experience with risk assessment, diet and transplantation J Inher Metab Dis 18 1998 111 114